Full text
PDF![110](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fdd/1305772/2ef7885b0c36/westjmed00312-0040.png)
![111](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fdd/1305772/6f031c03c414/westjmed00312-0041.png)
![112](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fdd/1305772/8f2a16e56fca/westjmed00312-0042.png)
![113](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fdd/1305772/2a4316868afa/westjmed00312-0043.png)
![114](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fdd/1305772/46e1b6bc4073/westjmed00312-0044.png)
![115](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fdd/1305772/3a97b4833910/westjmed00312-0045.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bacon B. R., Farahvash M. J., Janney C. G., Neuschwander-Tetri B. A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994 Oct;107(4):1103–1109. doi: 10.1016/0016-5085(94)90235-6. [DOI] [PubMed] [Google Scholar]
- Bacon B. R. Iron overload states. Clin Liver Dis. 1998 Feb;2(1):63-75, vi. doi: 10.1016/s1089-3261(05)70364-0. [DOI] [PubMed] [Google Scholar]
- Bergquist A., Broomé U. Clinical features in primary sclerosing cholangitis. Clin Liver Dis. 1998 May;2(2):283-301, viii. doi: 10.1016/s1089-3261(05)70008-8. [DOI] [PubMed] [Google Scholar]
- Bernard B., Lebrec D., Mathurin P., Opolon P., Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology. 1997 Jan;25(1):63–70. doi: 10.1053/jhep.1997.v25.pm0008985266. [DOI] [PubMed] [Google Scholar]
- Chau T. N., Patch D., Chan Y. W., Nagral A., Dick R., Burroughs A. K. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology. 1998 May;114(5):981–987. doi: 10.1016/s0016-5085(98)00640-4. [DOI] [PubMed] [Google Scholar]
- Córdoba J., Blei A. T. Treatment of hepatic encephalopathy. Am J Gastroenterol. 1997 Sep;92(9):1429–1439. [PubMed] [Google Scholar]
- D'Amico G., Morabito A., Pagliaro L., Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986 May;31(5):468–475. doi: 10.1007/BF01320309. [DOI] [PubMed] [Google Scholar]
- Davis G. L., Esteban-Mur R., Rustgi V., Hoefs J., Gordon S. C., Trepo C., Shiffman M. L., Zeuzem S., Craxi A., Ling M. H. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med. 1998 Nov 19;339(21):1493–1499. doi: 10.1056/NEJM199811193392102. [DOI] [PubMed] [Google Scholar]
- Dolan S. A. Vaccines for hepatitis A and B. The latest recommendations on safe and extended protection. Postgrad Med. 1997 Dec;102(6):74–80. doi: 10.3810/pgm.1997.12.377. [DOI] [PubMed] [Google Scholar]
- El-Serag H. B., Mason A. C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999 Mar 11;340(10):745–750. doi: 10.1056/NEJM199903113401001. [DOI] [PubMed] [Google Scholar]
- Ferenci P. Wilson's disease. Clin Liver Dis. 1998 Feb;2(1):31-49, v-vi. doi: 10.1016/s1089-3261(05)70362-7. [DOI] [PubMed] [Google Scholar]
- Ganger D. R., Klapman J. B., McDonald V., Matalon T. A., Kaur S., Rosenblate H., Kane R., Saker M., Jensen D. M. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol. 1999 Mar;94(3):603–608. doi: 10.1111/j.1572-0241.1999.00921.x. [DOI] [PubMed] [Google Scholar]
- Grace N. D. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol. 1997 Jul;92(7):1081–1091. [PubMed] [Google Scholar]
- Guevara M., Ginès P., Bandi J. C., Gilabert R., Sort P., Jiménez W., Garcia-Pagan J. C., Bosch J., Arroyo V., Rodés J. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology. 1998 Aug;28(2):416–422. doi: 10.1002/hep.510280219. [DOI] [PubMed] [Google Scholar]
- Jones D. E., James O. F., Bassendine M. F. Primary biliary cirrhosis: clinical and associated autoimmune features and natural history. Clin Liver Dis. 1998 May;2(2):265-82, viii. doi: 10.1016/s1089-3261(05)70007-6. [DOI] [PubMed] [Google Scholar]
- Lai C. L., Chien R. N., Leung N. W., Chang T. T., Guan R., Tai D. I., Ng K. Y., Wu P. C., Dent J. C., Barber J. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med. 1998 Jul 9;339(2):61–68. doi: 10.1056/NEJM199807093390201. [DOI] [PubMed] [Google Scholar]
- McCullough A. J., O'Connor J. F. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol. 1998 Nov;93(11):2022–2036. doi: 10.1111/j.1572-0241.1998.00587.x. [DOI] [PubMed] [Google Scholar]
- McHutchison J. G., Gordon S. C., Schiff E. R., Shiffman M. L., Lee W. M., Rustgi V. K., Goodman Z. D., Ling M. H., Cort S., Albrecht J. K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998 Nov 19;339(21):1485–1492. doi: 10.1056/NEJM199811193392101. [DOI] [PubMed] [Google Scholar]
- Nevens F., Main J., Honkoop P., Tyrrell D. L., Barber J., Sullivan M. T., Fevery J., De Man R. A., Thomas H. C. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology. 1997 Oct;113(4):1258–1263. doi: 10.1053/gast.1997.v113.pm9322520. [DOI] [PubMed] [Google Scholar]
- Rosen H. R. Liver disease associated with alpha1-antitrypsin deficiency. Clin Liver Dis. 1998 Feb;2(1):175–185. doi: 10.1016/s1089-3261(05)70370-6. [DOI] [PubMed] [Google Scholar]
- Runyon B. A. Management of adult patients with ascites caused by cirrhosis. Hepatology. 1998 Jan;27(1):264–272. doi: 10.1002/hep.510270139. [DOI] [PubMed] [Google Scholar]
- Wong D. K., Cheung A. M., O'Rourke K., Naylor C. D., Detsky A. S., Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med. 1993 Aug 15;119(4):312–323. doi: 10.7326/0003-4819-119-4-199308150-00011. [DOI] [PubMed] [Google Scholar]
- Yoshida E. M., Lake J. R. Selection of patients for liver transplantation in 1997 and beyond. Clin Liver Dis. 1997 Aug;1(2):247-61, vii. doi: 10.1016/s1089-3261(05)70269-5. [DOI] [PubMed] [Google Scholar]